Cell & gene Therapy LIMS

Built to Enforce GMP in Regulated Cell & Gene Therapy Operations

Labbit is the graph-native, workflow-first platform that unifies execution and compliance for cell and gene therapy by capturing every relationship as work happens for faster decisions and stronger compliance.

Trusted By

Vercyte Logo
Linus Bio Logo
Helix Logo
Billion To One Logo
Vercyte Logo
Linus Bio Logo
Helix Logo
Billion To One Logo
Vercyte Logo
Linus Bio Logo
Helix Logo
Billion To One Logo
Vercyte Logo
Linus Bio Logo
Helix Logo
Billion To One Logo

Cell & Gene Therapy Manufacturing Requires a Different Kind of LIMS

Cell and gene therapy manufacturing demands precise execution, complete traceability, and ongoing validation through change. Traditional LIMS often require custom code and significant validation effort to keep pace.

Labbit’s graph-native architecture connects patients, materials, samples, equipment, and quality events into a traceable, auditable data model. Version-controlled workflows and configuration changes help teams manage updates within a validated framework—without relying on developers.

Key Benefits for Cell & Gene Therapy

Flexibility Without the Validation Tax

By separating configuration and platform versions, workflow changes, new fields, and updated process parameters stay within the validated envelope. Teams can scope exactly which parts of the system were impacted, limiting revalidation to only what changed, not the system as a whole.

Traceable By Design, Not Through Reconstruction

Every action, every signature, every change is captured as a native property of the data—not assembled from separate log tables after the fact. That includes not just who did what and when, but the context, conditions, and sequence that explain why and how.

Compliance Enforced at the Decision Point

Labbit enforces compliance at the point of execution, through your SOPs, not around them. Invalid materials are blocked before use, workflow progression is gated on required approvals and open deviations, and e-signatures are enforced within controlled steps. Non-conformances are caught before they occur, not recorded and investigated later.

From Event to Full Context, Instantly

When an out-of-specification result, contamination event, or reagent recall occurs, Labbit's connected graph model lets investigators quickly traverse from the event to complete chain-of-custody in a single navigation. The result is faster root cause analysis, more defensible CAPAs, and quicker decisions when product timelines are at risk.

Process Intelligence, Built Into the Foundation

Because Labbit captures relationships as a native property of the data, teams can explore process patterns, identify sources of variation, and answer new scientific and operational questions without first restructuring data. Faster process optimization, reduced variability, and a foundation for advanced analytics and AI, without data engineering overhead.

One Platform, From Clinical to Commercial

Most LIMS platforms work until you outgrow them. Labbit is designed for the full arc — configurable enough to support evolving IND-stage workflows, structured for the traceability and audit demands of pre-approval inspection, and extensible enough to scale with increasing patient volumes and manufacturing complexity through BLA approval and commercial launch.

Solutions for Every Cell & Gene Therapy Modality

AUTOLOGOUS CELL THERAPY MANUFACTURING (CAR-T, TIL, TCR)

Complete Provenance for Patient-Specific Manufacturing

Labbit's graph-native data model captures chain-of-identity from apheresis to product release as a structural property of the data — linking patient, material, sample, operator, and quality event across every manufacturing step. Credential-backed e-signatures, real-time EM deviation flagging, and guided workflow enforcement ensure every action is captured in context at the point of execution. The result is an unbroken, inspection-ready record for every patient lot, without reconstruction and without the validation overhead legacy LIMS platforms add to every change.

Workflow dashboard showing sequential steps of an environmental monitoring process with timestamps, statuses marked 'Invalidated & Used,' and detailed sample information on the right side including label, type, status, collection details, and location.

VIRAL VECTOR & GENE THERAPY MANUFACTURING (AAV, LENTIVIRAL, CRISPR)

Controlled Evolution of Complex Gene Therapy Processes

Labbit's entity-centric model links plasmid to vector to patient dose as connected, traceable data, while structured workflows handle the complex branching, handoffs, and conditional routing multi-step vector manufacturing requires. As programs progress from clinical development through technology transfer and scale-up, assays and process parameters can be updated within a governed, validated framework. And because every configuration change is versioned and impact-scoped, teams can identify exactly what changed and limit revalidation to only what was affected.

ALLOGENEIC CELL THERAPY MANUFACTURING & IPSC-DERIVED PRODUCTS

Consistency and Lineage at Commercial Scale

From donor material through master and working cell banks, expansion, and differentiation, Labbit captures each stage as a connected record, giving teams the lineage visibility needed to demonstrate lot-to-lot consistency at scale. As release criteria are refined and production matures, workflows, assays, and process parameters stay adaptable without disrupting the validated state, so the system evolves alongside the program rather than against it.

Labbit software interface showing Stability Workflow with sections for Stability Study Protocol SSR, Study ID, Testing Results table listing sample IDs, pH, temperature, concentration, results, units, flags, and specifications.

CGT CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS

A Single Platform for Multi-Client GMP Operations

Labbit’s multi-environment architecture isolates each client’s data while maintaining consistent execution across programs, and its configuration layer supports diverse sponsor workflows without bespoke builds or client-specific system variants. Because every client program carries its own inspection exposure, Labbit keeps each IND or BLA’s traceability and audit trail fully separable — a configurable foundation for CDMOs managing high variability across clients without compromising control, compliance, or operational consistency.

Software interface showing a stability workflow diagram with steps: Create Study, Pull, Container Closure, Sterility, pH, Product Integrity, DNA, and Stability Report and Approval.

Key Features for Cell & Gene Therapy Labs

No-Code Workflow Configuration

Build, modify, and version GMP workflows without custom code or developer involvement.

Chain-of-Identity and -Custody Traceability

Link patients, materials, samples, and process steps as connected, auditable data—from origin to release.

Electronic Batch Records

Execute guided, SOP-enforced batch records with point-of-action e-signatures and full operator attribution.

Separate Dev, Test, & Production Environments

Validate and stage configuration changes before they reach production, without disrupting live operations.

Instrument & Software Integrations

Seamlessly connect to instruments, equipment, and systems to automate data capture and ensure consistent data flow across the lab.

AI and Analytics-Ready Data Capture

Capture process, sample, and quality data as connected graph data — ready for analysis without restructuring

Regulatory Compliance + Data Security

Labbit's dedicated-instance architecture isolates each organization's data at the database level delivering complete, provable separation your team can stand behind in any security review. SSO and MFA run through your own identity provider, and you control your own upgrade timing, so authentication, change control, and configuration stay under IT ownership. API-first integrations keep connections clean, documented, and resilient to version changes.

Abstract flowing waves in shades of purple and violet creating a smooth, dynamic texture.

Getting Started

See how Labbit works for labs like yours

Book a 30-minute demo to see visual workflow modeling, real-time execution visibility, and knowledge graph insights in action. We'll show you how Labbit adapts to your specific workflows — without the vendor lock-in.

FAQs

Frequently Asked Questions

What is a LIMS for cell and gene therapy manufacturing?

A cell and gene therapy LIMS is a laboratory informatics platform designed to support complex manufacturing workflows, maintain end-to-end traceability, and manage regulated processes across research, development, and production.

Labbit is built specifically to address these requirements by connecting patients, materials, samples, equipment, operators, and quality events within a single, traceable data model. This enables organizations to manage chain of identity, chain of custody, QC testing, and manufacturing workflows while maintaining data integrity and operational control.

What capabilities should a LIMS have for cell and gene therapy manufacturing?

A LIMS for cell and gene therapy should support capabilities such as chain of identity and custody tracking, electronic batch records, QC workflows, environmental monitoring, equipment management, audit trails, and flexible workflow configuration.

Labbit combines these capabilities with a graph-native architecture that captures relationships between data, processes, and events. Its no-code workflow configuration and real-time operational visibility help teams adapt processes as programs evolve while maintaining control over regulated operations.

How does a LIMS support chain of identity and chain of custody in cell therapy?

A LIMS supports chain of identity and chain of custody by maintaining a complete, traceable record of materials, samples, processing steps, and quality events throughout the therapy lifecycle.

Labbit’s graph-native data model connects patients, materials, samples, operators, equipment, and manufacturing activities, allowing teams to quickly understand the full history and lineage of a product without reconstructing information from disconnected systems.

How can a LIMS support changing cell and gene therapy workflows?

Cell and gene therapy workflows often evolve as processes move from research and development through clinical and commercial manufacturing. A LIMS should allow organizations to adapt processes, incorporate new requirements, and maintain control as operations change.

Labbit enables teams to configure and update workflows without custom code through no-code workflow configuration and version-controlled changes. Teams can track what changed, assess impact, and maintain a controlled, validated system as manufacturing processes evolve.

Why do cell and gene therapy manufacturers need a specialized LIMS?

Cell and gene therapy manufacturers need a specialized LIMS because these therapies require complex workflows, patient-specific traceability, strict regulatory controls, and the ability to adapt processes as programs move from development to commercialization.

Traditional LIMS often require custom development and significant validation effort to support these needs. Labbit provides a flexible, configurable platform that enables organizations to manage evolving workflows, maintain connected data, and support GMP operations without relying on extensive custom code.